EPSTATE SR 150 : Unlocking the Potential of Epalrestat Tablets ER (50mg)

EPSTATE SR 150 

Epalrestat Tablets ER (50mg)

EPSTATE SR 150, we delve into the efficacy, dosage guidelines, safety profile, and transformative potential of Epalrestat Tablets ER (50mg) in its extended-release formulation, shedding light on its pivotal role in alleviating the symptoms of diabetic neuropathy.

Understanding EPSTATE SR 150:

EPSTATE SR 150 encapsulates the therapeutic potency of Epalrestat Tablets ER (50mg) in its extended-release formulation. As a cornerstone in diabetic neuropathy management, EPSTATE SR 150 provides individuals grappling with neuropathic symptoms a reliable and efficacious option for symptom relief. Epalrestat, the active ingredient, exerts its therapeutic effects by inhibiting aldose reductase, thereby reducing the accumulation of sorbitol and preventing nerve damage associated with diabetic neuropathy.

Efficacy and Clinical Insights:

Extensive clinical trials and real-world data consistently demonstrate the efficacy of EPSTATE SR 150 in alleviating symptoms of diabetic neuropathy, including pain, numbness, and tingling sensations. Its extended-release formulation ensures sustained therapeutic levels of Epalrestat, leading to long-lasting symptom relief and improved functional outcomes for patients.

Dosage Guidelines and Administration:

Adherence to prescribed dosage regimens is essential for optimizing the therapeutic benefits of EPSTATE SR 150. The recommended dosage typically involves once-daily administration, preferably with meals, to enhance absorption and minimize gastrointestinal side effects. Close monitoring of symptoms and regular follow-up visits with healthcare providers allow for personalized adjustments to dosage regimens as needed.

Safety Profile and Adverse Effects:

Epalrestat Tablets ER (50mg) are generally well-tolerated, with minimal systemic side effects reported. Common adverse effects may include gastrointestinal discomfort, such as nausea and abdominal pain, which are usually mild and transient. Severe adverse reactions are rare, highlighting the favorable safety profile of EPSTATE SR 150 in diabetic neuropathy management.

Interactions and Precautions:

Although Epalrestat Tablets ER (50mg) has a favorable safety profile, it is essential to consider potential drug interactions and precautions. Caution should be exercised in patients with hepatic impairment, as Epalrestat is primarily metabolized by the liver. Additionally, patients should be advised to avoid alcohol consumption, as it may exacerbate liver-related adverse effects.

Patient Education and Empowerment:

Empowering patients with comprehensive knowledge about EPSTATE SR 150 is essential for fostering treatment adherence and optimizing outcomes. Patients should be educated about the importance of medication adherence, potential side effects, and lifestyle modifications to manage diabetic neuropathy effectively. Encouraging open communication and regular follow-up visits with healthcare providers empower patients to take an active role in managing their condition. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW